Propafenone vs placebo or no treatment
All‐cause mortality · adults in sinus rhythm after cardioversion of atrial fibrillation
It is very uncertain whether propafenone changes all‐cause mortality compared with placebo or no treatment (very low certainty).
1 finding from 1 review
- Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation 2019 · Cochrane Headline outcomes onlyRR 0.19 [0.02, 1.68]2 studies · 212 participantsVery low